Delivery Order SPE2DB22D2211-SPE2DB23FPFF8
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $38
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injections. The firm fixed price order is for the delivery of 4562252108 units of methotrexate at 50 mg/2 ml per vial with a total of 2 ml per vial. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania between September 20-21, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other government...
- The Defense Logistics Agency awarded a $21,080 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. Under the firm fixed price contract, Amerisourcebergen will provide 4561781216 units of 50 mg/2 mL methotrexate in 2 mL vials to the DLA from its facility in Conshohocken, Pennsylvania. The order period of performance is August 11-14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this award supports the DLA's mission to provide medical...
- The Defense Logistics Agency awarded a $69,370 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by July 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate will support the DLA's mission to provide...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-one thousand four hundred dollars to Amerisourcebergen Drug Corporation for the supply of methotrexate injection vials. The prime contractor will deliver 4561400700 units of METHOTREXATE 50 MG/2 ML VIAL 2ML to a location in Conshohocken, Pennsylvania between July 3rd and July 5th, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports military readiness by...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at twenty-eight thousand four hundred thirty dollars to Amerisourcebergen Drug Corporation for methotrexate injection. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply two milliliter vials of the drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from July 19th through July...
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by June 23, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate is consistent with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the purchase of methotrexate injection vials. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program and calls for the delivery of 4561400454 units of methotrexate 50 mg/2 ml vials to a facility in Conshohocken, Pennsylvania. Performance will take place between July 3 and July 5, 2023. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-six thousand three hundred dollars to Amerisourcebergen Drug Corporation for the supply of methotrexate injection vials. As the prime contractor, Amerisourcebergen will deliver one hundred vials of methotrexate at two hundred fifty milligrams per ten milliliters to a facility in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the contract. The Defense Logistics Agency utilizes contracts such...
- The Defense Logistics Agency awarded a $45,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561309047, methotrexate 250 mg/10 ml vials packaged in quantities of 10 ml. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from June 20, 2023 to June 21, 2023. No major subcontractors or set aside designations were indicated. This delivery order...
- The Defense Logistics Agency Troop Support Medical awarded a $18,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561323709 methotrexate 50 mg/2 ml vials. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 2 ml vials of methotrexate to a facility in Conshohocken, Pennsylvania. The period of performance is June 23, 2023 through June 26, 2023. No subcontractors or set aside...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FPFF8Delivery Order
The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. Under this firm fixed price contract, Amerisourcebergen will provide 4562251958 units of methotrexate at 50 mg per 2 ml vial from its facility in Conshohocken, Pennsylvania. The single-day period of performance for this delivery order spans September 20 through 21, 2023. No subcontractors or set-aside designations were identified. The award utilizes an existing DLA pharmaceuticals contract vehicle to fulfill U.S. military treatment facility requirements for this chemotherapy medication.
Generated 12/20/23, 9:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38 | 9/20/23 |